Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis

Background and objective:  Although pulmonary rehabilitation is effective for patients with COPD, its efficacy in patients with IPF is unknown. The purpose of this study was to evaluate the effects of pulmonary rehabilitation in IPF.

[1]  Y. Kondoh,et al.  Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD. , 2007, Respiratory medicine.

[2]  C. Lenfant,et al.  Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .

[3]  Johny Verschakelen,et al.  High-dose acetylcysteine in idiopathic pulmonary fibrosis. , 2005, The New England journal of medicine.

[4]  Y. Kondoh,et al.  Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis. , 2005, Chest.

[5]  S. Kudoh,et al.  Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2005, American journal of respiratory and critical care medicine.

[6]  Y. Kondoh,et al.  Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? , 2005, Respiratory medicine.

[7]  G. Raghu,et al.  The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis , 2005, European Respiratory Journal.

[8]  G. Raghu,et al.  A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. , 2004, The New England journal of medicine.

[9]  F. Martinez,et al.  Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. , 2003, American journal of respiratory and critical care medicine.

[10]  R. Casaburi.  Limitation to exercise tolerance in chronic obstructive pulmonary disease: look to the muscles of ambulation. , 2003, American journal of respiratory and critical care medicine.

[11]  M. Okazawa,et al.  The effect of pulmonary rehabilitation in patients with post-tuberculosis lung disorder. , 2003, Chest.

[12]  S. Nagai,et al.  Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis. , 2002, Internal medicine.

[13]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[14]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[15]  J. Tooze,et al.  Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. , 2001, American journal of respiratory and critical care medicine.

[16]  C. Rochester,et al.  Exercise training in chronic obstructive pulmonary disease. , 2003, Journal of rehabilitation research and development.

[17]  S. Aguayo,et al.  Idiopathic pulmonary fibrosis: a practical approach for diagnosis and management. , 2000, Chest.

[18]  M. Decramer,et al.  Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. , 2000, The American journal of medicine.

[19]  G H Guyatt,et al.  Long-term effects of outpatient rehabilitation of COPD: A randomized trial. , 2000, Chest.

[20]  N. Payne,et al.  Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial , 2000, The Lancet.

[21]  J. Hankinson,et al.  Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. , 2000, American journal of respiratory and critical care medicine.

[22]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[23]  N. Hopkinson,et al.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. , 2009, American journal of respiratory and critical care medicine.

[24]  G. Raghu,et al.  Assessment of health-related quality of life in patients with interstitial lung disease. , 1999, Chest.

[25]  Murray D. Altose,et al.  Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. , 1999, American journal of respiratory and critical care medicine.

[26]  R. Zuwallack,et al.  Pulmonary rehabilitation - 1999 , 1999 .

[27]  M. Tsukino,et al.  Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[28]  C. Cooper,et al.  Exercise and interstitial lung disease. , 1998, Current opinion in pulmonary medicine.

[29]  J. Myers,et al.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.

[30]  M. Tsukino,et al.  Comparison of Discriminative Properties among Disease-specific Questionnaires for Measuring Health-related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease , 1998 .

[31]  Alison E. Ries.  Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation. , 1997, Chest.

[32]  R. Mostert,et al.  Long-term outcome of pulmonary rehabilitation in patients with COPD. , 1997, Chest.

[33]  M. Wittmann.  [Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease]. , 1997, Pneumologie.

[34]  R. Casaburi,et al.  Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.

[35]  M. Tsukino,et al.  Physiologic factors that determine the health-related quality of life in patients with COPD. , 1996, Chest.

[36]  M. Decramer,et al.  Peripheral muscle weakness contributes to exercise limitation in COPD. , 1996, American journal of respiratory and critical care medicine.

[37]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[38]  G. Guyatt,et al.  Randomised controlled trial of respiratory rehabilitation , 1994, The Lancet.

[39]  I. Tsuyuguchi,et al.  [Prediction formulas for pulmonary function tests expressed in linear and exponential form for healthy Japanese adults]. , 1992, Nihon Kyobu Shikkan Gakkai zasshi.

[40]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[41]  R. Casaburi,et al.  Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. , 1991, The American review of respiratory disease.

[42]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[43]  H. M. Thomas,et al.  Pulmonary rehabilitation in lung disease other than chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.

[44]  C. Wells,et al.  The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. , 1984, Chest.